Vertex Pharmaceuticals Incorporated v. Rea
1:13-cv-00653
Overview
Parties
Defendant
Teresa Stanek Rea NPE (Individual / Inventor)
Represented By
1 Attorneys ListedUS Attorney's Office (Alexandria-NA)
2100 Jamieson Avenue, Alexandria, VA 22314
Plaintiff
Vertex Pharmaceuticals Incorporated NPE (Individual / Inventor)
Represented By
1 Attorneys ListedSteptoe & Johnson LLP
1330 Connecticut Avenue, N.W., Washington, DC 20036-1795
Court & Judges
Court
District Court, E.D. Virginia (vaed)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US8324242
Modulators of ATP-binding cassette transporters
|
Filed: 2009-01-09
Issued: 2012-12-04
|
Active (0.7 yrs remaining)
Expires: 2027-08-05
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
2
Dispositive
0
Granted
1
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings